±¾´ÎÈ϶¨Ö÷ÒªÒÀ¾ÝHS-20089-101Ñо¿µÄIÆÚÊÔÑé½á¹ûºÍHS-20089-201Ñо¿µÄ¢òÆÚÊÔÑé½á¹û¡£HS-20089-101Ñо¿ÊÇÒ»Ïî¶àÖÐÐÄ¡¢¿ª·Å±êÇ©µÄIÆÚÁÙ´²ÊÔÑ飬ÆÀ¼Û×¢ÉäÓÃHS-20089ÔÚÍíÆÚʵÌåÁö»¼ÕßÖеݲȫÐÔ¡¢ÄÍÊÜÐÔ¡¢µÏÍþ¹ú¼Ê´ú¶¯Á¦Ñ§ºÍÓÐЧÐÔ¡£HS-20089-201Ñо¿ÊÇÒ»Ïî¶àÖÐÐÄ¡¢¿ª·Å±êÇ©µÄ¢òÆÚÁÙ´²ÊÔÑ飬ÔÚ¸´·¢ÐÔ»ò×ªÒÆÐÔÂѳ²°©ºÍ×Ó¹¬ÄÚĤ°©»¼ÕßÖÐÆÀ¼ÛHS-20089¾²Âö×¢É䏸µÏÍþ¹ú¼ÊµÄÓÐЧÐÔ¡¢°²È«ÐÔ¡¢µÏÍþ¹ú¼Ê´ú¶¯Á¦Ñ§ÌØÕ÷ºÍÃâÒßÔÐÔ¡£
HS-20089ÊÇÒ»¿îB7-H4°ÐÏòADC£¬ÆäÓÐÐ§ÔØºÉÎªÍØÆËÒ칹øÒÖÖÆ¼Á£¨TOPOi£©£¬ÕýÓÚÖйú¿ªÕ¹ÓÃÓÚÖÎÁÆÂѳ²°©ÒÔ¼°ÆäËû¸¾¿ÆÖ×ÁöµÄ¶àÏîÁÙ´²Ñо¿£¬ÆäÖÐ×î¸ßÑо¿½×¶ÎΪÁÙ´²¢óÆÚ¡£2023Äê10ÔÂ20ÈÕ£¬µÏÍþÖÆµÏÍþ¹ú¼ÊÓëGSK¶©Á¢¶À¼ÒÐí¿ÉÐÒ飬ÊÚÓèGSKÈ«Çò¶ÀÕ¼Ðí¿É£¨²»º¬ÖйúÄڵء¢Ïã¸Û¡¢°ÄÃż°Ì¨Í壩£¬ÒÔ¿ª·¢¡¢Éú²ú¼°ÉÌÒµ»¯HS-20089£¨GSK5733584£©£¬¸Ã²úƷĿǰÕýÓÉGSK¿ªÕ¹º£Íâ¢ñÆÚÁÙ´²ÊÔÑé¡£
µÏÍþÖÆµÏÍþ¹ú¼ÊÏÖÒѲ¼¾Ö¶à¸ö½øÕ¹¿¿Ç°¡¢¾ßÓвîÒ컯µÄADC·Ö×Ó£¬²¢¸ßÐ§ÍÆ½øÆäÁÙ´²¿ª·¢¼°×¢²áÉêÇ룬ÒÔÆÚÔçÈÕΪÖйúÄËÖÁÈ«Çò»¼Õß´øÀ´¸ü¶àÍ»ÆÆÐÔÖÎÁÆÑ¡Ôñ¡£
Âѳ²°©£¨OC£©ÊÇ×î³£¼ûµÄ¸¾¿Æ¶ñÐÔÖ×ÁöÖ®Ò»£¬2022Ä꣬ȫÇòÔ¼Õï¶Ï³ö324,603ÀýÂѳ²°©Ð²¡Àý£¬Ê¹Æä³ÉΪŮÐÔÖеڰ˴󳣼û¶ñÐÔÖ×Áö¡£¸ÃÄêÔ¼ÓÐ206,956ÀýÂѳ²°©ËÀÍö£¬Âѳ²°©³ÉΪŮÐÔ°©Ö¢Ïà¹ØËÀÍöµÄµÚ°Ë´óÔÒò¡£ÔÚÖйú£¬2022ÄêÂѳ²°©µÄ·¢²¡ÊýΪ61,060Àý£¬ËÀÍöÈËÊýΪ32,646Àý[1] ¡£
ÊÖÊõÁªºÏÒÔ²¬Îª»ù´¡µÄ»¯ÁÆÊÇĿǰÂѳ²°©µÄ±ê×¼ÖÎÁÆ·½Ê½£¬µ«¾ø´ó²¿·ÖÍíÆÚ»¼Õß»áÔÚ3ÄêÄÚ¸´·¢£¬²¢×îÖÕ»á¶Ô²¬À໯ÁƲúÉúÄ͵ÏÍþ¹ú¼ÊÐÔ£¬²¬Ä͵ÏÍþ¹ú¼Ê¸´·¢Âѳ²°©£¨PROC£©µÄÁÙ´²ÖÎÁÆÊֶκÍÁÆÐ§¾ùÊ®·ÖÓÐÏÞ¡£¸ù¾Ý½üÄêÀ´¿ªÕ¹µÄ¢óÆÚËæ»ú¶ÔÕÕÑо¿ÖеĶÔÕÕ×飨·Ç²¬µ¥µÏÍþ¹ú¼Ê»¯ÁÆ£©Êý¾ÝÏÔʾ£¬·Ç²¬µ¥µÏÍþ¹ú¼Ê»¯ÁÆÂѳ²°©µÄ¿Í¹Û»º½âÂÊ£¨ORR£©½ö4%~15.9%£¬ÖÐλÎÞ½øÕ¹Éú´æÆÚ£¨mPFS£©½ö3.4~3.98¸öÔ¡£¶ÔÓÚ½ÓÊܹý1ÖÁ2ÏßÖÎÁƵϼÕߣ¬·Ç²¬»¯ÁƽáºÏ±´·¥Öéµ¥¿¹µÄORRΪ27.3%£¬mPFSÑÓ³¤ÖÁ6.7¸öÔ£¬ÖÐλÉú´æÆÚ£¨mOS£©´ïµ½16.6¸öÔ¡£¾¡¹ÜPFSÏÔÖøÑÓ³¤£¬µ«OSÓë·Ç²¬»¯ÁÆÏà±ÈÎÞÃ÷ÏÔ»ñÒæ[2-6] ¡£Ä¿Ç°¸Ã¼²²¡ÈÔ´æÔÚ¾Þ´óδ±»Âú×ãµÄÁÙ´²ÐèÇ󣬨½´ýѰÕÒ¸üΪÓÐЧµÄÖÎÁÆ·½Ê½¡£
¸ù¾Ý¡¶¹ú¼ÒµÏÍþ¹ú¼ÊÆ·¼à¶½¹ÜÀí¾Ö¹ØÓÚ·¢²¼Í»ÆÆÐÔÖÎÁƵÏÍþ¹ú¼ÊÎïÉóÆÀ¹¤×÷³ÌÐò£¨ÊÔÐУ©µÈÈý¸öÎļþµÄ¹«¸æ¡·£¨2020ÄêµÚ82ºÅ£©£¬Í»ÆÆÐÔÖÎÁƵÏÍþ¹ú¼ÊÎï³ÌÐòÊÊÓ÷¶Î§Îª¡ª¡ªµÏÍþ¹ú¼ÊÎïÁÙ´²ÊÔÑéÆÚ¼ä£¬ÓÃÓÚ·ÀÖÎÑÏÖØÎ£¼°ÉúÃü»òÕßÑÏÖØÓ°ÏìÉú´æÖÊÁ¿µÄ¼²²¡£¬ÇÒÉÐÎÞÓÐЧ·ÀÖÎÊֶλòÕßÓëÏÖÓÐÖÎÁÆÊÖ¶ÎÏà±ÈÓÐ×ã¹»Ö¤¾Ý±íÃ÷¾ßÓÐÃ÷ÏÔÁÙ´²ÓÅÊÆµÄ´´ÐµÏÍþ¹ú¼ÊµÈ¡£Õë¶ÔÄÉÈëÍ»ÆÆÐÔÖÎÁƵÏÍþ¹ú¼ÊÎï³ÌÐòµÄµÏÍþ¹ú¼ÊÎCDEÓÅÏÈÅäÖÃ×ÊÔ´½øÐйµÍ¨½»Á÷£¬¼Óǿָµ¼²¢´Ù½øµÏÍþ¹ú¼ÊÎïÑз¢£»²¢ÇÒ¾ÆÀ¹À·ûºÏÏà¹ØÌõ¼þµÄ£¬Ò²¿ÉÒÔÔÚÉêÇëµÏÍþ¹ú¼ÊÆ·ÉÏÊÐÐí¿ÉʱÌá³ö¸½Ìõ¼þÅú×¼ÉêÇëºÍÓÅÏÈÉóÆÀÉóÅúÉêÇë¡£
²Î¿¼ÎÄÏ×£º
[1]International Agency for Research on Cancer. (2024). Cancer TODAY: GLOBOCAN 2022 (version 1.1). Retrieved April 26, 2025, from https://gco.iarc.who.int
[2]Pujade-Lauraine E, Fujiwara K, Ledermann JA, et al. Lancet Oncol. Jul 2021;22(7):1034-1046.
[3] Gaillard S, Oaknin A, Ray-Coquard I, et al. Gynecol Oncol. Nov 2021;163(2):237-245.
[4]Hamanishi J, Takeshima N, Katsumata N, et al. J Clin Oncol. Nov 20 2021;39(33):3671-3681.
[5]Pujade-Lauraine E, Hilpert F, Weber B, et al.
[6]Moore KN, Angelergues A, Konecny GE, et al. N Engl J Med. Dec 7 2023;389(23):2162-2174.
ÉùÃ÷£º
1¡¢±¾¹«¸æ½ö¹©Ò½ÁÆÎÀÉúרҵÈËÊ¿²ÎÔÄ£¬·Ç¹ã¸æÓÃ;¡£
2¡¢µÏÍþÖÆµÏÍþ¹ú¼Ê²»ÍƼöÈκÎδ»ñÅúµÏÍþ¹ú¼ÊƷʹÓúÍ/»òδ»ñÅúÊÊÓ¦Ö¢ÓõÏÍþ¹ú¼Ê£¬Ò಻¶ÔÈκεÏÍþ¹ú¼ÊÆ·ºÍ/»òÊÊÓ¦Ö¢×÷ÍÆ¼ö¡£
3¡¢±¾¹«¸æÖÐÉæ¼°µÄÐÅÏ¢½ö¹©²Î¿¼£¬Çë×ñ´ÓÒ½Éú»òÆäËûÒ½ÁÆÎÀÉúרҵÈËÊ¿µÄÒâ¼û»òÖ¸µ¼¡£Ò½ÁÆÎÀÉúרҵÈËÊ¿×÷³öµÄÈκÎÓëÖÎÁÆÓйصľö¶¨Ó¦¸ù¾Ý»¼ÕߵľßÌåÇé¿ö²¢×ñÕÕµÏÍþ¹ú¼ÊƷ˵Ã÷Êé¡£
4¡¢ÈçÐèÁ˽⹫˾ÈκβúÆ·¡¢Ò½ÁÆ»ò¼²²¡µÄÏà¹ØÐÅÏ¢£¬ÇëÎñ±Ø×ÉѯҽÁÆÎÀÉúרҵÈËÊ¿¡£
ǰհÐÔ˵Ã÷
±¾ÐÂΟåÖ¼ÔÚÌṩ¹ØÓÚµÏÍþÖÆµÏÍþ¹ú¼Ê¼¯ÍÅÓÐÏÞ¹«Ë¾¼°Æä¸½Êô¹«Ë¾£¨°üÀ¨Æä×Ó¹«Ë¾£¬Í³³ÆÎª¡°µÏÍþÖÆµÏÍþ¹ú¼Ê¡±£©µÄÐÅÏ¢¡£Ëü²»¹¹³É¶ÔµÏÍþÖÆµÏÍþ¹ú¼Ê»òÈκÎͶ×ʽ¨ÒéµÄÐÅÏ¢Åû¶¡£
±¾ÐÂΟå°üº¬µÄÐÅÏ¢¿ÉÄܰüÀ¨ÓëµÏÍþÖÆµÏÍþ¹ú¼ÊÒµÎñºÍ²úƷǰ¾°¡¢¼Æ»®¡¢ÐÅÄî¡¢Ô¤ÆÚºÍ²ßÂÔÏà¹ØµÄǰհÐÔÉùÃ÷¡£ÕâЩÉùÃ÷ÊÇ»ùÓÚÍÆ²âÐÔ¼ÙÉèµÄÔ¤²â£¬²¢²»±£Ö¤Î´À´µÄ±íÏÖ¡£ËüÃÇÊܵ½ÖîÈç¿ÆÑ§¡¢ÉÌÒµ¡¢ÕþÖΡ¢¾¼Ã¡¢²ÆÎñ¡¢·¨ÂÉÒòËØÒÔ¼°¾ºÕù»·¾³ºÍÉç»áÌõ¼þµÈ·çÏպͲ»È·¶¨ÐÔµÄÓ°Ï죬ÕâЩÒòËØºÜ¶à¶¼ÊǵÏÍþÖÆµÏÍþ¹ú¼ÊÎÞ·¨¿ØÖÆÇÒÄÑÒÔÔ¤²âµÄ£¬Òò´Ëʵ¼Ê½á¹û¿ÉÄÜÓë´Ë´¦ËùÊöÓÐÏÔÖø²îÒ죬ÇÒ¹ýÈ¥µÄ֤ȯ¼Û¸ñÇ÷ÊÆ²»Ó¦×÷ΪδÀ´ÐÐÇéµÄÖ¸µ¼¡£Òò´Ë£¬Í¶×ÊÕßÔÚʹÓÃÕâЩÐÅÏ¢½øÐÐͶ×ʾö²ßʱӦ½÷É÷ÐÐÊ¡£¡°ÖÂÁ¦ÓÚ¡±¡°Ô¤ÆÚ¡±¡°ÏàÐÅ¡±¡°Ô¤²â¡±¡°Òâͼ¡±¡°Ô¤¼Æ¡±¡°¿ÉÄÜ¡±¡°½«¡±¡°Ó¦¸Ã¡±¡°¼Æ»®¡±¡°¼ÌÐø¡±¡°Ä¿±ê¡±¡°¿¼ÂÇ¡±¡°¹À¼Æ¡±¡°Ö¸µ¼¡±¡°Ç±ÔÚ¡±¡°×·Çó¡±ÒÔ¼°ÓÚÈκÎδÀ´¼Æ»®¡¢Ðж¯»òʼþµÄÌÖÂÛÖÐʹÓõÄÀàËÆ´ÊÓïºÍÊõÓ¾ù±íʾǰհÐÔÉùÃ÷¡£
µÏÍþÖÆµÏÍþ¹ú¼Ê²»³Ðŵ»ò±£Ö¤Ç°Õ°ÐÔÐÅÏ¢µÄ׼ȷÐÔ¡¢¼°Ê±ÐÔ»òÍêÕûÐÔ£¬²¢ÇÒ²»³Ðµ£¸üлòÐÞ¶©ÕâЩǰհÐÔÉùÃ÷µÄÒåÎñ¡£ÎÞÂÛÊǵÏÍþÖÆµÏÍþ¹ú¼Ê»¹ÊÇÆäÈκζÊ¡¢Ô±¹¤»ò´úÀíÈË£¬¾ù²»¶ÔÈκÎÖ¤Ã÷²»×¼È·»òÎÞ·¨ÊµÏÖµÄǰհÐÔÉùÃ÷¸ºÔð£¬Ò²²»¶ÔÒòÒÀÀµ±¾ÐÂΟåÖÐÌṩµÄÐÅÏ¢¶ø²úÉúµÄÈκÎËðʧ»òË𺦸ºÔ𣬰üÀ¨µ«²»ÏÞÓÚÖ±½Ó¡¢Å¼È»¡¢¼ä½Ó»ò³Í·£ÐÔµÄË𺦡£